Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects

The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V 1 receptor stimulation. However, a possible antidiuretic effect by V 2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. T...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Renal physiology Vol. 295; no. 5; pp. F1295 - F1300
Main Authors Krag, Aleksander, Bendtsen, Flemming, Pedersen, Erling Bjerregaard, Holstein-Rathlou, Niels-Henrik, Møller, Søren
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.11.2008
Subjects
Online AccessGet full text
ISSN1931-857X
1522-1466
DOI10.1152/ajprenal.90407.2008

Cover

Abstract The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V 1 receptor stimulation. However, a possible antidiuretic effect by V 2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V 2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C[Formula: see text]), urine osmolality (U osm ), and fractional distal water excretion (DFeH 2 O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73–214 ng/mmol creatinine, P = 0.001]. C[Formula: see text] decreased 1.05 ml/min (from 0.17 to −0.89 ml/min, P = 0.001), and DFeH 2 O decreased 37% (19 vs. 12; 95% CI 2–11, P = 0.01). U osm increased by 27% (93 mosmol/kgH 2 O, 95% CI 23–164 mosmol/kgH 2 O, P = 0.02). Plasma sodium decreased 1.1 mmol/l ( P < 0.01). An increase in AQP2 excretion and a decrease in C[Formula: see text] and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V 2 receptor effect).
AbstractList The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V 1 receptor stimulation. However, a possible antidiuretic effect by V 2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V 2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C[Formula: see text]), urine osmolality (U osm ), and fractional distal water excretion (DFeH 2 O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73–214 ng/mmol creatinine, P = 0.001]. C[Formula: see text] decreased 1.05 ml/min (from 0.17 to −0.89 ml/min, P = 0.001), and DFeH 2 O decreased 37% (19 vs. 12; 95% CI 2–11, P = 0.01). U osm increased by 27% (93 mosmol/kgH 2 O, 95% CI 23–164 mosmol/kgH 2 O, P = 0.02). Plasma sodium decreased 1.1 mmol/l ( P < 0.01). An increase in AQP2 excretion and a decrease in C[Formula: see text] and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V 2 receptor effect).
The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C(H2O)), urine osmolality (Uosm), and fractional distal water excretion (DFeH2O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. C(H2O) decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH2O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). Uosm increased by 27% (93 mosmol/kgH2O, 95% CI 23-164 mosmol/kgH2O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C(H2O) and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V2 receptor effect).
The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V... receptor stimulation. However, a possible antidiuretic effect by V... receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V... receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (...), urine osmolality (...), and fractional distal water excretion (DFeH...O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. ... decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH...O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). ... increased by 27% (93 mosmol/kgH...O, 95% CI 23-164 mosmol/kgH...O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V... receptor effect). (ProQuest: ... denotes formulae/symbols omitted.)
The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C(H2O)), urine osmolality (Uosm), and fractional distal water excretion (DFeH2O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. C(H2O) decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH2O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). Uosm increased by 27% (93 mosmol/kgH2O, 95% CI 23-164 mosmol/kgH2O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C(H2O) and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V2 receptor effect).The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C(H2O)), urine osmolality (Uosm), and fractional distal water excretion (DFeH2O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. C(H2O) decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH2O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). Uosm increased by 27% (93 mosmol/kgH2O, 95% CI 23-164 mosmol/kgH2O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C(H2O) and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V2 receptor effect).
Author Pedersen, Erling Bjerregaard
Holstein-Rathlou, Niels-Henrik
Møller, Søren
Krag, Aleksander
Bendtsen, Flemming
Author_xml – sequence: 1
  givenname: Aleksander
  surname: Krag
  fullname: Krag, Aleksander
– sequence: 2
  givenname: Flemming
  surname: Bendtsen
  fullname: Bendtsen, Flemming
– sequence: 3
  givenname: Erling Bjerregaard
  surname: Pedersen
  fullname: Pedersen, Erling Bjerregaard
– sequence: 4
  givenname: Niels-Henrik
  surname: Holstein-Rathlou
  fullname: Holstein-Rathlou, Niels-Henrik
– sequence: 5
  givenname: Søren
  surname: Møller
  fullname: Møller, Søren
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18753292$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9LxDAQxYMo6q5-AkGKB29dk7RJG28i_oMFERS8hTSdYJY2XZNU8Nubta4HD55mhvm9d3hvhnbd4AChE4IXhDB6oVZrD051C4FLXC0oxvUOOkwfmpOS8920i4LkNateD9AshBXGmBBK9tEBqStWUEEP0dONMaBjyAaTRfCdTZ4hWJcNLotvkKn3UXmIVmfhM0ToLzP4sC04DRuFctG2dpwAmJyO0J5RXYDjnzlHL7c3z9f3-fLx7uH6apnrktKYG1I1mrRC1aUGSuu2ErgBXgrKmpZpzhnWhDWqacp0Co4ZBVMLYZQwQjdVMUfnk-_aD-8jhCh7GzR0nXIwjEFyUbGyrHkCz_6Aq2H0KbggaYEJJpyxBJ3-QGPTQyvX3vbKf8ptUgkQE6D9EIIHI7WNKtrBRa9sJwmWm1bkthX53YrctJK0xR_tr_0_qi-JaJN7
CitedBy_id crossref_primary_10_1177_2050640618781205
crossref_primary_10_1177_030006051204000512
crossref_primary_10_1016_j_ijso_2022_100494
crossref_primary_10_1016_j_jhep_2024_02_015
crossref_primary_10_1111_apt_12653
crossref_primary_10_1177_2050640619878996
crossref_primary_10_1177_1756283X09102330
crossref_primary_10_1002_hep_24065
crossref_primary_10_1080_14740338_2020_1734558
crossref_primary_10_1002_hep_23893
crossref_primary_10_1016_j_biopha_2023_115116
crossref_primary_10_2147_JEP_S416673
crossref_primary_10_1007_s10072_015_2250_x
crossref_primary_10_1002_14651858_CD013123_pub2
crossref_primary_10_3390_ijms23063068
crossref_primary_10_1177_0976500X231175220
crossref_primary_10_1111_imj_12121
crossref_primary_10_1111_jgh_14009
crossref_primary_10_4199_C00085ED1V01Y201305ISP039
crossref_primary_10_1016_j_phrs_2016_08_027
crossref_primary_10_1038_ajg_2016_168
crossref_primary_10_1155_2017_7610374
crossref_primary_10_1080_00365520902912555
crossref_primary_10_3109_00365513_2010_537369
crossref_primary_10_1002_hep_24095
crossref_primary_10_1186_2193_1801_2_519
crossref_primary_10_1136_bmj_m2687
crossref_primary_10_1016_j_crphar_2023_100163
crossref_primary_10_1080_00365521_2020_1744709
crossref_primary_10_1007_s12325_008_0118_7
crossref_primary_10_1097_MCG_0000000000000217
crossref_primary_10_3904_kjm_2014_87_3_323
crossref_primary_10_1038_nrneph_2013_22
crossref_primary_10_14712_23362936_2016_7
crossref_primary_10_1177_17562848221098253
crossref_primary_10_3109_00365521_2010_510576
crossref_primary_10_3390_metabo15020072
crossref_primary_10_3748_wjg_v20_i42_15499
crossref_primary_10_7759_cureus_64576
crossref_primary_10_3109_00365521_2015_1021709
crossref_primary_10_1111_jcpt_13031
crossref_primary_10_1111_jgh_13641
Cites_doi 10.1677/joe.0.0850237
10.1113/jphysiol.1987.sp016745
10.1681/ASN.V891357
10.1152/physrev.00024.2001
10.1152/physrev.00053.2006
10.1152/ajprenal.2001.280.5.F860
10.1007/BF00543482
10.1002/hep.21094
10.1097/00042737-200202000-00009
10.1053/j.gastro.2008.02.024
10.1006/bbrc.1994.2150
10.1056/NEJM199506083322303
10.1002/hep.21414
10.1002/hep.21901
10.1053/j.gastro.2008.02.014
10.1097/00000542-200609000-00026
10.1074/jbc.274.45.32248
10.1016/S0168-8278(00)80158-0
10.1053/jhep.2002.35819
10.1016/S0168-8278(96)80118-8
10.1016/S0168-8278(97)80456-4
10.1002/hep.1840400410
ContentType Journal Article
Copyright Copyright American Physiological Society Nov 2008
Copyright_xml – notice: Copyright American Physiological Society Nov 2008
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1152/ajprenal.90407.2008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1466
EndPage F1300
ExternalDocumentID 1594468241
18753292
10_1152_ajprenal_90407_2008
Genre Research Support, Non-U.S. Gov't
Controlled Clinical Trial
Journal Article
GroupedDBID ---
23M
2WC
39C
4.4
53G
5GY
5VS
6J9
8M5
AAFWJ
AAYXX
ACPRK
ADBBV
AENEX
AFFNX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BTFSW
C1A
CITATION
E3Z
EBS
EJD
EMOBN
F5P
GX1
H13
ITBOX
KQ8
OK1
P2P
PQQKQ
RAP
RHI
RPL
RPRKH
TR2
W8F
WOQ
XSW
YSK
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c422t-f17bc1d9a84ce228d790be64925bd5c6650c15babb4d5c96052ef899fa9f9cb73
ISSN 1931-857X
IngestDate Thu Jul 10 18:44:14 EDT 2025
Mon Jun 30 08:06:48 EDT 2025
Mon Jul 21 06:07:54 EDT 2025
Tue Jul 01 03:46:14 EDT 2025
Thu Apr 24 22:52:13 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c422t-f17bc1d9a84ce228d790be64925bd5c6650c15babb4d5c96052ef899fa9f9cb73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 18753292
PQID 230101655
PQPubID 48265
ParticipantIDs proquest_miscellaneous_69754486
proquest_journals_230101655
pubmed_primary_18753292
crossref_citationtrail_10_1152_ajprenal_90407_2008
crossref_primary_10_1152_ajprenal_90407_2008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-11-01
PublicationDateYYYYMMDD 2008-11-01
PublicationDate_xml – month: 11
  year: 2008
  text: 2008-11-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
PublicationTitle American journal of physiology. Renal physiology
PublicationTitleAlternate Am J Physiol Renal Physiol
PublicationYear 2008
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References R21
R20
R23
R22
R25
R24
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R12
R11
R14
R13
R16
R15
R18
R17
R19
References_xml – ident: R3
  doi: 10.1677/joe.0.0850237
– ident: R7
– ident: R10
  doi: 10.1113/jphysiol.1987.sp016745
– ident: R21
  doi: 10.1681/ASN.V891357
– ident: R16
  doi: 10.1152/physrev.00024.2001
– ident: R2
  doi: 10.1152/physrev.00053.2006
– ident: R20
  doi: 10.1152/ajprenal.2001.280.5.F860
– ident: R19
  doi: 10.1007/BF00543482
– ident: R15
  doi: 10.1002/hep.21094
– ident: R5
  doi: 10.1097/00042737-200202000-00009
– ident: R12
  doi: 10.1053/j.gastro.2008.02.024
– ident: R6
  doi: 10.1006/bbrc.1994.2150
– ident: R8
  doi: 10.1056/NEJM199506083322303
– ident: R1
  doi: 10.1002/hep.21414
– ident: R22
– ident: R9
  doi: 10.1002/hep.21901
– ident: R23
  doi: 10.1053/j.gastro.2008.02.014
– ident: R24
  doi: 10.1097/00000542-200609000-00026
– ident: R17
  doi: 10.1074/jbc.274.45.32248
– ident: R25
  doi: 10.1016/S0168-8278(00)80158-0
– ident: R18
  doi: 10.1053/jhep.2002.35819
– ident: R13
  doi: 10.1016/S0168-8278(96)80118-8
– ident: R4
  doi: 10.1016/S0168-8278(97)80456-4
– ident: R11
– ident: R14
  doi: 10.1002/hep.1840400410
SSID ssj0001121
Score 2.1202226
Snippet The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V 1 receptor stimulation. However, a possible antidiuretic effect by V...
The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2...
The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V... receptor stimulation. However, a possible antidiuretic effect by...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage F1295
SubjectTerms Adolescent
Adult
Aged
Antidiuretic Agents - pharmacology
Aquaporin 2 - urine
Arginine Vasopressin - blood
Blood Pressure - drug effects
Blood Pressure - physiology
Creatinine - urine
Cyclic AMP - urine
Drinking - drug effects
Drinking - physiology
Drugs
Female
Hepatorenal Syndrome - drug therapy
Hepatorenal Syndrome - metabolism
Hormones
Humans
Kidney - drug effects
Kidney - physiology
Lithium - urine
Lypressin - analogs & derivatives
Lypressin - pharmacology
Lypressin - therapeutic use
Male
Middle Aged
Osmolar Concentration
Receptors, Vasopressin - agonists
Sodium - blood
Studies
T cell receptors
Urine
Urine - chemistry
Vasoconstrictor Agents - pharmacology
Water - metabolism
Water-Electrolyte Balance - drug effects
Water-Electrolyte Balance - physiology
Young Adult
Title Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects
URI https://www.ncbi.nlm.nih.gov/pubmed/18753292
https://www.proquest.com/docview/230101655
https://www.proquest.com/docview/69754486
Volume 295
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1522-1466
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001121
  issn: 1931-857X
  databaseCode: KQ8
  dateStart: 19971001
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1522-1466
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001121
  issn: 1931-857X
  databaseCode: KQ8
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1522-1466
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001121
  issn: 1931-857X
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuCFoeS3n4gHqBlMYbxwm3gnZVQVso2pX2FtmOU23LJu1ucoC_wR9m7EweFeV5ibJOHK88n8cznhchL1LN05Hh3DNCCi8ACd-LVGh9pkDBDeAudU40R8fhwSx4P-fzweB7z2upKtWu_nZtXMn_UBXagK42SvYfKNt-FBrgHugLV6AwXP-KxuPOGcM6Zi5qp9YcDQAv5WUlXZAi5mt2VXiwiqiz_-flIl1U9Svo2NEXVltrTi-9hDsJcUfxu0Aa29i1tMx7JU8xeOZ87aJnWqXf5GmJZz6AmOWy2Tgdc7Y-1XgetHJR8m_PzGplTiVG_mMIxdoW6PQ-WzeQoqrRDBu8Z8MtFudXTjEiDOfrGG888r2Ii3mfM7O6_iZCkPf47MTHZz_vANxmlJVnNiMoaC8xMCnhXGa7Da8x8h9_TCazw8NkOp5Pdy4uPVuKzJrssS7LDXKTiTC0ZTE-nHQp6EFA9WtXhfoPYyorGPf1NaNeFXd-ocM4WWZ6l9xBJYTu14i6RwYm3yRb-7ksi-VXukM_tSTdJLeO0Ptii5wg3miR0T7eaJFTwBtt8UZrvL2hDdpsjz7aKKLtPplNxtN3Bx6W5PB0wFjpZb5Q2k9jGQXaMAYrOd5TJrQZLlXKdQjyvva5kkoF8BO0Y85MBip9JuMs1kqMHpCNvMjNI0KZjoQwsL0ZJkFrMEqLIIizUMUmzNJIDAlrZi7RmK_elk35kji9lbOkme7ETbcrqDokr9pOF3W6lt-_vt2QJMGltE5AKXdBfnxInrdPgelaS5rMTVGtkzC2eSOjcEge1nTsBrP6P4vZ4z_23Sa3u4XwhGyUq8o8BQG3VM8c4H4AeXiu8A
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+terlipressin+on+the+aquaretic+system%3A+evidence+of+antidiuretic+effects&rft.jtitle=American+journal+of+physiology.+Renal+physiology&rft.au=Krag%2C+Aleksander&rft.au=Bendtsen%2C+Flemming&rft.au=Pedersen%2C+Erling+Bjerregaard&rft.au=Holstein-Rathlou%2C+Niels-Henrik&rft.date=2008-11-01&rft.issn=1931-857X&rft.volume=295&rft.issue=5&rft.spage=F1295&rft_id=info:doi/10.1152%2Fajprenal.90407.2008&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-857X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-857X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-857X&client=summon